Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Indometacin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Indometacin 50mg capsules
1001010K0AAABAB
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 15,034 |
|
Indometacin 25mg capsules
1001010K0AAAAAA
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 10,548 |
|
Indometacin 100mg suppositories
1001010K0AAAFAF
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 499 |
|
Indometacin 25mg/5ml oral suspension
1001010K0AABBBB
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 167 |
|
Indometacin 75mg modified-release capsules
1001010K0AAADAD
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 64 |
|
Indometacin 25mg/5ml oral solution
1001010K0AAAQAQ
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 21 |
|
Indocid 100mg suppositories
1001010K0BDADAF
|
Indocid | Indometacin | Musculoskeletal and Joint Diseases | 5 |
|
Indometacin 5mg/5ml oral liquid
1001010K0AABABA
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 4 |
|
Indometacin 10mg/5ml oral liquid
1001010K0AAAXAX
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 1 |
|
Indometacin 75mg modified-release tablets
1001010K0AAAJAJ
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 1 |
|
Berlind 75 Retard capsules
1001010K0BXAAAD
|
Berlind | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Flexin-25 Continus tablets
1001010K0BNACAL
|
Flexin Continus | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Flexin-50 Continus tablets
1001010K0BNABAK
|
Flexin Continus | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Flexin-75 Continus tablets
1001010K0BNAAAJ
|
Flexin Continus | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indocid 25mg capsules
1001010K0BDAAAA
|
Indocid | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indocid 50mg capsules
1001010K0BDABAB
|
Indocid | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indocid 5mg/ml oral suspension
1001010K0BDACAE
|
Indocid | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indocid PDA 1mg powder for solution for injection vials
0701011E0BBAAAA
|
Indocid (Neonatal) | Indometacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Indocid R 75mg capsules
1001010K0BDAFAD
|
Indocid | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indolar SR 75mg capsules
1001010K0BGADAD
|
Indolar | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indomax 75 SR capsules
1001010K0BQABAD
|
Indomax | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 1.2mg/5ml oral liquid
1001010K0AAATAT
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 12mg/5ml oral liquid
1001010K0AAAYAY
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 15mg/5ml oral liquid
1001010K0AAAZAZ
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | No data available |
|
Indometacin 1mg powder for solution for injection vials
0701011E0AAAAAA
|
Indometacin (Neonatal) | Indometacin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.